Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-11

FDA Approved: HYDROCODONE BITARTRATE — Supplemental Application (Alvogen Inc.)

View source ↗

Summary

FDA approved a supplemental application from Alvogen Inc. for hydrocodone bitartrate, a generic opioid analgesic product. The approval updates the ANDA entry to…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCODONE BITARTRATE (HYDROCODONE BITARTRATE)

Snippet

SUPPL AP for HYDROCODONE BITARTRATE (HYDROCODONE BITARTRATE)